BridgeBio Pharma agrees with US government to expand Medicaid and Medicare Part D access to Attruby, without future pricing mandates

BridgeBio Pharma has reached an agreement with the US government to expand access to its drug Attruby under Medicaid and Medicare Part D. The deal does not include future pricing mandates.